Overview Antiretroviral Therapy for Acute HIV Infection Status: Withdrawn Trial end date: 2025-09-14 Target enrollment: Participant gender: Summary This study will evaluate the virologic effect, safety and tolerability of Genvoya® in adults during early acute HIV infection. Phase: N/A Details Lead Sponsor: Henry M. Jackson Foundation for the Advancement of Military MedicineCollaborator: Gilead SciencesTreatments: Anti-Retroviral AgentsCobicistatElvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationEmtricitabineGenvoyaTenofovir